Results 181 to 190 of about 609,352 (314)

Diet Quality of Young Children in the US-Affiliated Pacific's Children's Healthy Living (CHL) Program. [PDF]

J Acad Nutr Diet, 2023
Dela Cruz R, Novotny R, Wilkens LR, Shvetsov YB, Yamanaka AB, Butel J, Aflague TF, Coleman P, Shallcross L, Deenik J, Mapa VLR, Boushey CJ, Fleming T.   +12 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Framework for Identifying Signature Foods for Health in the Children's Healthy Living Program in the United States Affiliated Pacific Region. [PDF]

J Nutr
Wilkens LR, Dela Cruz R, Yamanaka AB, Hammond K, Shvetsov YB, Aflague T, Butel J, Coleman P, Fleming T, Shallcross L, Fialkowski MK, Young C, Ing C, Franck K, Esquivel M, Novotny R.   +15 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Examining the uptake, retention, and effectiveness of a national online type 2 diabetes self-management intervention in England (Healthy Living): A retrospective cohort study. [PDF]

PLoS One
Zghebi SS, Cotterill S, Marsden A, Paterson L, Elliott RA, McMillan B, Rutter MK, Kontopantelis E.   +7 more
europepmc   +1 more source

Assessment of Doubly Disadvantaged Neighborhoods by Healthy Living Environment Exposure. [PDF]

Appl Spat Anal Policy, 2023
Liu D, Kwan MP, Kan Z.
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Infectious disease outcomes associated with inadequate housing and access to healthy living practices in Australia: a systematic review. [PDF]

BMJ Public Health
Summer K, Anpalagan K, Stacey I, Stiles S, Burgess R, Wade V, Bowen AC, Katzenellenbogen J, Wyber R.   +8 more
europepmc   +1 more source

Enhancing the utilization of healthy living interventions among cancer survivors in historically underserved populations and communities. [PDF]

Cancer Causes Control, 2023
Raber M, Rechis R, LaRue DM, Ho-Pham TT, Oestman K, Walsh MT, Kizub D, Ma H, Galvan E, Zhao H, Gonzalez J, Lei X, Hu J, Basen-Engquist K.   +13 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source